Boohoo said Mahmud Kamani would move aside as chairman on the same day that Frasers called for his removal, the latest twist in a spat between the online fashion company and its majority shareholder.
Related Posts
Regeneron, Sanofi Get FDA OK for Dupixent to Treat COPD
Regeneron Pharmaceuticals and Sanofi have won FDA expanded approval of their blockbuster anti-inflammatory drug Dupixent in chronic obstructive pulmonary disease.
Atos Debt Grows as Restructuring Effort Continues
Atos said its debt pile grew in the third quarter as the beleaguered French IT firm seeks to implement a financial restructuring aimed at restoring […]
Eli Lilly Cuts Sales Outlook After Sluggish Growth for Incretin Drugs
- staff
- January 14, 2025
- 0
Eli Lilly cut its outlook for fourth-quarter revenue citing sluggish growth in the market for incretin, which increases insulin levels.